Umbilical Cord Blood Cell Transplants May Help ALS Patients

Researchers transplanted human umbilical cord blood cells into mouse models with amyotrophic lateral sclerosis to determine which of three dose strength levels -- low, moderate and high -- delayed symptom progression and increased lifespan. Moderate strength doses of HUCB cells proved most effective and may have provided a neuroprotective effect for motor neurons through active involvement of the cells in modulating the host immune inflammatory system response.

Read the whole article on Science Daily

More from Science Daily